Understanding Acute Back Pain Risks
Acute low back pain (LBP) is an all-too-common ailment that many people face at some point in their lives. While it often resolves naturally, the way we treat it can significantly impact our health in the long run. Interestingly, a recent study indicates that starting treatment with opioids or gabapentinoids can lead to serious risks, including opioid use disorder (OUD) and overdose.
The Numbers Don't Lie: Risk of Opioid Use Disorder
According to a study published in JAMA Network Open by Dr. Kara E. Rudolph and colleagues, patients who received opioids or gabapentinoids as their first line of therapy were faced with an alarming increase in the risk of OUD or overdose. Specifically, those treated with lower doses of opioids (less than 50 mg morphine equivalents) were 105.2% more likely to experience these outcomes. Even higher doses posed an even greater threat—an increase of 146.6% for those prescribed over 50 mg in morphine equivalents!
Non-Pharmacological Treatments: A Safer Alternative
The study uncovered a stark contrast for those who opted for manual, nondrug therapies as their initial treatments. Patients who started with chiropractic care or physical therapy saw a reduced risk for OUD or overdose—by 32.8% and 31.1% respectively. These findings further emphasize the need to consider nonpharmacological approaches before turning to potent medications.
Rethinking Pain Management Strategies
For well over a decade, health guidelines have discouraged the initial use of opioids for treating acute LBP. The recognition of the opioid crisis stemming from aggressive pain management practices has led to this shift. With prior recommendations urging powerful painkillers as a treatment for pain, the rise in overdoses and addiction rates demanded a reevaluation of that approach.
Understanding the Broader Context
The opioid epidemic emerged largely due to a misguided perspective that pain should be treated aggressively. Gabapentinoids also entered the spotlight as safer alternatives, but like opioids, their efficacy in treating LBP remains questionable. The data presented by Dr. Rudolph and her team illustrate a clear need for a return to safer, evidence-based treatment methods.
Moving Forward: Responsible Pain Management
As patients navigate treatment options, it's crucial to be informed about the risks associated with different therapies. The study's findings reinforce the importance of discussing both pharmacological and nonpharmacological options with healthcare providers, empowering patients to advocate for safer pain management strategies.
As you seek care for acute low back pain, consider discussing these insights with your healthcare provider. Opting for first-line nonpharmacological therapies may greatly reduce the risks connected to opioid prescriptions while still effectively managing pain.
Write A Comment